Turkey - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use

Since 2014, Turkey Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use increased 6.6% year on year. In 2019, the country was number 16 comparing other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use at 75.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Turkey is overtaken by Greece, which was ranked number 15 with 75.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Denmark with 73.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands lead the ranking with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 3.9% compared to 2018. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada recorded the best 5 years average growth at +11.3% per year, while Austria recorded the worst performance at -14% per year.

Loading...

Date Units (Defined Daily Dosage) Per Thousand Persons Per Day
2019 75.40
2018 75.80
2017 66.60
2016 59.20
2015 59.60
Download all data from 2008 to 2019

How does Turkey rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?

# 28 Countries Units (Defined Daily Dosage) Per Thousand Persons Per Day Last YoY 5‑years CAGR
1 #1
Netherlands
132 2019 +3.9 % +3.5 % View data
2 #2
Spain
129 2019 +2.8 % +0.6 % View data
15 #15
Greece
76 2019 +1.3 % +5.6 % View data
16 #16
Turkey
75 2019 -0.5 % +6.6 % View data
17 #17
Denmark
74 2019 +2.9 % +3.0 % View data
Compare all 28 countries

Go Top